Go

Breaking News on Pharmaceutical Technology

All news articles

Videos
Audio-podcasts
Weekly comments
November 2009
October 2009
Previous months

On your radar

Globalisation
Lifecycle management
Counterfeiting
Mergers and acquisitions

News Headlines

Materials & Formulation
Processing & QC
Packaging
Industry Drivers

All feeds

All news articles > December 2007

« Previous month Next month »

21-Dec-2007

FMC expands excipient production

FMC BioPolymer is to expand its microcrystalline cellulose (MCC) production in a bid to meet demand for the company's excipients.

Pharmaceutical manufacturing: news in brief

In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

New company formed for drug delivery tech

Jerusalem-based Yissum has formed a spin-off company Nanolymf, which will be dedicated to advancing a nanotechnology controlled-release drug delivery platform.

20-Dec-2007

Consort Medical feeling the loss of Exubera

Consort Medical's UK operations may be in line for more job losses as further collateral damage from Pfizer's withdrawal of Exubera from the market.

Keata buys Pfizer's Canadian facility

PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's manufacturing facility in Arnprior, Canada, which the drug giant has been trying to pass on for over a year.

Flamel tech used for Merck Serono drug

France-based Flamel Technologies and Merck Serono have shook hands on a new €2m ($2.9m) deal which would see Flamel's Medusa technology used to develop an extended-release profile of an undisclosed therapeutic protein.

19-Dec-2007

William Ransom & Son's future profitability questionable

UK-based William Ransom & Son has a shaky future ahead following a disappointing and unacceptable six-month financial report, compounded by a suspension of the companys manufacturing license.

New drug on the blocks for athletes

Scientists have discovered a potential new drug target that will prick up the ears of sportsmen and athletes alike. Not that this is an performance-enhancing drug; instead, it could help athletes recover from injury more quickly.

Biopartners ends supply agreement with TMH

Biopartners has terminated its supply agreement with The Medical House because of a go-slow in receiving functional drug delivery devices.

Pharmaceutical manufacturing: people on the move

Eli Lilly, Shire, Pregis, and Eisai have all had people on the move in the world of pharmaceutical manufacturing.

18-Dec-2007

Chao Centre gets rights to manufacture TB drug

Eli Lilly has handed over the manufacturing reins of the antibiotic Seromycin to the Chao Centre for Industrial Pharmacy and Contract Manufacturing.

Siegfried and Arena sign contract manufacturing deal

Siegfried has signed a $27.7m contract with Arena Pharmaceuticals to manufacture Arena's Phase III oral obesity drug candidate lorcaserin hydrochloride.

Excipient market set to change, says report

Advances in the pharmaceutical industry are expected to have an impact on pharmaceutical excipients within the next decade, a new report claims.

17-Dec-2007

Patheon reveals plans to tackle Puerto Rico problems

Patheon has finally revealed its plans to tackle the ongoing problems it has been facing with its Puerto Rican operations, which are draining the firm of profitability.

Pronova and FMC to develop seaweed-derived capsules

Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology.

Japan says Tamiflu/psychiatric link unclear

Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government.

14-Dec-2007

Pharmaceutical manufacturing: news in brief

In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

Double whammy as Merck kids' vaccines recalled and suspended

Merck has been hit with a contamination threat prompting the recall of a million of its childhood Hib vaccines across the US, right alongside the Canadian suspension of its MMR vaccine.

13-Dec-2007

Novozymes and Millipore to supply cell culture supplements

Novozymes and Millipore are to supply animal-free cell culture supplements to the biopharmaceutical industry.

Novartis launches initiative with 2,500 job losses

Novartis is to sever a further 2,500 jobs as part of a new initiative aimed to 'improve competitiveness in a dynamically changing healthcare environment'.

Pharmaceutical patent round-up

In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations.

China's API manufacturers facing further crackdowns

The first steps in tightening the safety controls on the pharmaceutical ingredients imported to the US from China have been taken following months of negotiations between the regulatory bodies of the two countries.

12-Dec-2007

Merck confirms diabetes retreat

Merck Serono intends to forge ahead with severing its investment in diabetes and either sell or partner out its existing research and development (R&D) activities in this field, which it no longer feels able to compete in effectively.

BioWa and Lonza agreement for potent antibodies

BioWa and Lonza are joining forces to develop a new technology platform to produce more potent antibodies with enhanced cell-killing powers.

NNE wins Pronova contract

NNE Pharmaplan has won a contract with Pronova BioPharma to build the company's new pharma production facility in Kalundborg, Denmark.

Pharmaceutical manufacturing: people on the move

Vyteris, Sciele Pharma, Nektar Therapeutics, Fundamental Applied Biology and Artes Medical have all had people on the move in the world of pharmaceutical manufacturing.

West Pharma unit to suffer in post-Exubera fallout

The repercussions of Pfizer's dramatic Exubera exit are finally filtering through to West Pharmaceutical Services, with the company preparing to restructure its affected Tech Group contract manufacturing unit.

11-Dec-2007

Hikma still in 'acquisition mode' on APM buy

Hikma has ticked another pharma firm off its shopping list as it acquires the Arab Pharmaceutical Manufacturing Company (APM) for $163.6m.

GE Healthcare and Novavax collaborate on pandemic flu solution

GE Healthcare and Novavax have a vision - a state-of-the-art pandemic influenza vaccine manufacturing facility solution with the ability to produce vaccines quickly, which can be marketed as a product to international countries.

Eli Lilly signals vigour for outsourcing

Eli Lilly is the latest big pharma company to signal plans of a vigorous commitment to outsourcing in a bid to prevent its fortunes fading.

Carl Zeiss licenses 'record-breaking' fluorescence technology

Microscopy expert-Carl Zeiss has licensed a new fluorescence microscopy technique that enables scientists to determine the precise intracellular location of proteins of interest.

10-Dec-2007

Eisai continues biologics push with $3.9bn MGI Pharma buy

Japanese drugmaker Eisai has agreed to buy US biopharma firm MGI Pharma for $3.9bn (€2.7bn) in a bid to expand its US presence and strengthen its oncology pipeline.

Transport wins for elecrokinetic drug delivery

Transport Pharmaceuticals has been named the 2007 North American Technology Innovation of the Year Award winner in electrokinesis-enabled drug delivery.

Contract manufacturing news in brief

Vetter, New England Peptide, Urigen Pharmaceuticals, Servac, and Patheon have all recently announced contract manufacturing news.

Puerto Rico pursuing biologic bucks

Puerto Rico is making a concerted effort to attract biologic investment dollars onto the island as it falls foul of a retreat from pharma firms seeking solid dose manufacturing.

07-Dec-2007

William Ransom & Son recall false contaminated products

UK-based William Ransom & Son has been advised to voluntarily recall certain products following a false contamination scare at its Witham, Essex, facility.

Pharmaceutical manufacturing: news in brief

In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry.

Millipore partners Rohm and Haas to develop new chromatography media

Separations expert Millipore is collaborating with Rohm and Haas Company to develop new high-performance chromatography products for use in biopharmaceutical manufacturing.

06-Dec-2007

DSM and Arch go for API manufacturing deal

DSM Anti-Infectives has signed up India's Arch Pharmalabs in a multi-year contract to manufacture generic active pharmaceutical ingredients (APIs).

BMS reveals plans to trim the fat

Bristol-Myers Squibb (BMS) has finally detailed its plans to trim the fat and save cash, months after first revealing that big changes would be on the cards.

Abbott cuts jobs, closes plant in Ireland

Abbott is to shut its doors on its Galway, Ireland, facility - taking 500 jobs with it - as the market moves into murky waters over the future of vascular stents.

Sanofi steps up Asian investment

Sanofi-Aventis has opened its first Asian research and development centre in Goa, India, signalling its ambition to further tap in to this region's budding pharma scene.

05-Dec-2007

Arius and Avid team up

Arius Research and Avid Bioservices have joined forces in the manufacturing and development of an anticancer antibody.

Combo products need guidelines

The combination products market is zooming ahead, requiring the need to address regulatory challenges, an author of a white paper says.

Separating mixtures in an NMR machine

Canadian researchers have devised a method of extracting the complete proton NMR (nuclear magnetic resonance) spectra for a component of a mixture without the need for physical separation.

Pharmaceutical manufacturing: people on the move

Pharmaceutical Profiles, H.D. Smith, Consort Medical, Questcor Pharmaceuticals, and Sunesis Pharmaceuticals have all had people on the move in the world of pharmaceutical manufacturing.

04-Dec-2007

CMC buys Lilly/ICOS facility

Denmark-based CMC Biopharmaceuticals has snapped up Eli Lilly's recently acquired biologics facility for an undisclosed amount.

India's Glenmark pioneering through prioritising preclinical

Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority.

Medgenics gets (bio)pumping

Medgenics' Biopump could be the solution to the issues surrounding protein therapy and is set to take on the $51bn US biopharmaceutical market after raising £3.28m ($6.76m) in funding in its Initial Public Offering.

Paraytec to lead biopharmaceutical sizing collaboration

Paraytec has been chosen to lead a £1m (€1.4m) consortium project to develop new analytical instruments that will detect aggregation in biopharmaceutical processing.

03-Dec-2007

Boehringer boosts biopharma base

Boehringer Ingelheim has completed a hefty makeover of its biopharmaceutical production plant in Biberach, Germany.

Pfizer plans more off-shoring and outsourcing

Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs.

Almirall takes on big pharma in COPD

Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house pipeline.

Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline

Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline and now, true to its word, the French pharma heavyweight has signed a big antibody deal with US biotech Regeneron.

« Previous month Next month »

Sign up for your free newsletter

On-Demand Webinars, Videos, Audio

Technical & Research papers

Products, Brochures, Web links

Related sites

All Decision News Media Sites

Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe

Partners | Events | About us | Site map | All sites | Recommend this Site | Advertise | Contact the Editor | Terms & Conditions | Privacy Policy

© 2000/2009 - Decision News Media SAS - All right reserved.Decision News Media